Hope against hep C
Friday, September 3, 2010 at 2:26PM New medicines are being developed that are expected to transform the care of patients with hepatitis C, making treatment far more effective and far less grueling.
The new drugs, which could start reaching the market as early as next year, could help subdue a virus that infects roughly four million Americans, most of them baby boomers, and 170 million people worldwide.
"I almost think this will be revolutionary, to be honest,' said Dr Fred Poordad, chief of hepatology at Cedars-Sinai Medical Centre in Los Angeles. "We are chomping at the bit to try to treat as many patients as we can".
About two dowzen pharmeceutical companies are now pursuing drugs for hepatitis C, which an executive at Vertex Pharmaceuticals recently called "one of the largest pharmaceutical opportunities this decade."
To see full article CLICK HERE




